APP Pharmaceuticals, Praised For Easing Drug Shortages, Gets Manufacturing Warning Letter

APP is singled out for helping alleviate the shortage of the cancer drug methotrexate at the same time the company’s manufacturing plant in Grand Island, N.Y. is cited for numerous cGMP violations.